People with obesity or overweight and type 2 diabetes lost up to 13.1% of their body weight with survodutide over 76 weeks.

With next-generation metabolic combinations continuing to set new standards in the clinic, type 2 diabetes and chronic weight ...

The European Association for the Study of Diabetes and the American Diabetes Association have updated their joint guidance on T2D management.

Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

The Danish global pharmaceutical company Novo Nordisk claimed that its late stage trial had met its main goal of reducing glucose (BG) levels in a trial involving about 1,200 patients over a ...

Henagliflozin, a popular drug prescribed for type 2 diabetes, has demonstrated potential anti-aging effects in a recent study published in Cell Reports Medicine. Telomeres are protective caps made of ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ...

The Deep Structure of Risks in the Off-Label Use of MounjaroWith the widespread use of Mounjaro (tirzepatide), its off-label ...

Trial focused on younger adults with early-onset diabetes ...

The type 2 diabetes market is expected to witness steady growth, driven by the rising global prevalence of diabetes, increasing rates of obesity and sedentary lifestyles, and growing awareness of ...